NKGen Biotech, Inc.: investing cash flow
Investing cash flow for NKGen Biotech, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All NKGen Biotech, Inc. financial histories
What this measure means
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
Exact concept: us-gaap:NetCashProvidedByUsedInInvestingActivities. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2021-01-28 to 2024-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2024-01-01 | 2024-12-31 | -13,000 | USD | 2025-10-08 | 10-K · 0001845459-25-000004 |
| 2023-01-01 | 2023-12-31 | -48,000 | USD | 2025-10-08 | 10-K · 0001845459-25-000004 |
| 2022-01-01 | 2022-12-31 | -163,000 | USD | 2024-04-16 | 10-K · 0001845459-24-000007 |
| 2021-01-28 | 2021-12-31 | -171,615,000 | USD | 2023-03-31 | 10-K · 0001410578-23-000580 |
Related financial histories
- NKGen Biotech, Inc.: total assets
- NKGen Biotech, Inc.: total liabilities
- NKGen Biotech, Inc.: stockholders equity
- NKGen Biotech, Inc.: cash and cash equivalents
- NKGen Biotech, Inc.: net income or loss
- NKGen Biotech, Inc.: operating cash flow
- NKGen Biotech, Inc.: financing cash flow
- NKGen Biotech, Inc.: retained earnings or deficit
- NKGen Biotech, Inc.: basic weighted-average shares
- NKGen Biotech, Inc.: diluted weighted-average shares
- NKGen Biotech, Inc.: basic earnings per share
- NKGen Biotech, Inc.: diluted earnings per share
- NKGen Biotech, Inc.: income tax expense or benefit
- NKGen Biotech, Inc.: net property, plant and equipment
- NKGen Biotech, Inc.: share-based compensation expense
- NKGen Biotech, Inc.: operating income or loss
- NKGen Biotech, Inc.: current assets
- NKGen Biotech, Inc.: current liabilities
- NKGen Biotech, Inc.: current accounts payable
- NKGen Biotech, Inc.: research and development expense
Inspect the source
- Entity
- NKGen Biotech, Inc. / CIK 0001845459
- Captured
- 2026-09-21T17:32:02.047Z
- SEC response SHA-256
8544e6c4131b39516897f64f9c1434fcc316a28920c7035efe74b5652ec44a1a
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001845459.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))